Navigation Links
Study Finds Utilizing Integrated Medical and Pharmacy Data Improves Ability to Forecast Use of High-cost Specialty Treatments
Date:4/20/2012

ded to properly identify treatment candidates for other conditions. The study suggested that identifying where gaps in care exist through the use of pharmacy and medical data, can help health plans enhance outcomes for members using specialty medications.

To identify specialty condition prevalence, diagnosis and treatment, researchers from Prime reviewed integrated pharmacy and medical data from 2.6 million commercial and Health Maintenance Organization (HMO) members. Fifteen specialty conditions/drug classes were identified and defined internally.

Of the continuously enrolled members, the prevalence among the 15 specialty conditions ranged from a low of 13 members per 100,000 in hemophilia to 1,607 members per 100,000 in cancer. The majority of conditions (12 of 15) were found in less than 200 per 100,000 members. A low percentage of members identified with cancer were defined as currently treated (13.8 percent). This finding is understandable as cancer patients may be receiving palliative care or in remission. The conditions/drug classes with the highest percentage of treated members were transplant/immunosuppressants (94 percent), cystic fibrosis (93 percent) and HIV (92.8 percent). The most untreated condition was macular degeneration (7 percent).

"Based on the prevalence, number of members treated and drug spend found in the study, it is becoming increasingly apparent that health insurers need to understand treatment patterns for cancer and autoimmune conditions," Gleason said. "For example, the second most common specialty condition of Rheumatoid Arthritis (RA)/Psoriasis had less than half (44.0%) of patients treated with a specialty drug. Increasing the use of drugs in only a small percent of this untreated population would have a dramatic impact on expenditures. Utilizing specialty medication analyses based on medical and pharmacy data allows health insurers to identify important trends and patterns in the specialty drug space that may
'/>"/>

SOURCE Prime Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... WASHINGTON , Sept. 16, 2014 The ... (NYSE: LLY ) today released results from ... that sheds light on the lupus journey and the ... also for lupus caregivers. The UNVEIL study, which involved ... the devastating impact lupus has on all aspects of ...
(Date:9/16/2014)... DIEGO , Sept. 16, 2014 Imprimis ... pharmaceutical company dedicated to delivering high quality and novel ... announced that Chief Executive Officer Mark Baum ... Annual Craig-Hallum Alpha Select Conference in New York City.  ... its Go Dropless™ campaign in ophthalmology. The presentation ...
(Date:9/16/2014)... NEW YORK , Sept. 16, 2014  Relmada ... therapies for the treatment of chronic pain, announced today ... Sloan Kettering Cancer Center (MSKCC) in a series of ... ER, a new tamper-resistant, extended release form of levorphanol. ... investigator for these studies. Dr. Pasternak ...
Breaking Medicine Technology:"UNVEIL" Survey Reveals a Life Interrupted by Lupus 2"UNVEIL" Survey Reveals a Life Interrupted by Lupus 3"UNVEIL" Survey Reveals a Life Interrupted by Lupus 4"UNVEIL" Survey Reveals a Life Interrupted by Lupus 5Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 2Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 3Imprimis Pharmaceuticals to Present at Craig-Hallum Alpha Select Conference 4Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 2Relmada Therapeutics Enters Into Agreement with Memorial Sloan Kettering to Better Clarify Unique Mechanism of Action for LevoCap ER 3
... LEIDEN, The Netherlands, July 6 Three ... Therapeutics and InteRNA,Technologies - have joined public-private partnership TI ... on cancer and,inflammatory diseases, have a total budget of ... The new consortium, formed by Syncom, Synvolux Therapeutics, and,University ...
... , NEW YORK, June 30 Betsy McCaughey of the Committee ... hospital infection rates made available by the NYS Department of Health ... have the lowest infection rates - and steer clear of those ... , Betsy McCaughey, a Ph.D., founded RID in 2004 with a ...
Cached Medicine Technology:New Small and Medium Sized Enterprises Join TI Pharma by Signing Two New Projects 2
(Date:9/16/2014)... September 16, 2014 Today, Top 10 ... the most recommended suppliers for the webmasters for people ... save money at the same time. , As an ... ) has been offering useful products at low prices ... connected to multiple GB connections to ensure that there ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Recently, the ... compared a lot of SEO hosting suppliers and announced ... most recommended suppliers for webmasters from the USA, UK, ... products (including VPS and cloud hosting) without spending a ... easy to use shared SEO hosting plans come with ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Care ... Logistics™, a component of the Hospital Operating System™ ... match patient needs with staff capacity. For the ... understanding of actual nursing and other staff capacity. ... of patient-care needs, anticipated admissions, discharges and transfers, ...
(Date:9/16/2014)... Randy Dotinga HealthDay Reporter , ... pattern baldness may face a higher risk of developing an ... a new study suggests. But, the study authors noted ... pattern of baldness should be concerned. Their study only found ... It did not prove cause and effect. "It is ...
(Date:9/16/2014)... September 15, 2014 Combining a standard chemotherapy ... from dividing improves both the survival and response ... new study by UT Southwestern Medical Center cancer ... the chemotherapy drug cisplatin with pemetrexed - an ... showed promising results for advanced, persistent, or recurrent ...
Breaking Medicine News(10 mins):Health News:Top 10 Best SEO Hosting: These Companies Are The Best Cheap SEO Hosting Suppliers In 2014 2Health News:Great SEO Hosting Suppliers Announced By Top 10 Best SEO Hosting 2Health News:Care Logistics Launches Demand Logistics as Part of the Hospital Operating System 2Health News:Male Pattern Baldness Tied to Prostate Cancer, Study Suggests 2Health News:Male Pattern Baldness Tied to Prostate Cancer, Study Suggests 3Health News:Cancer-fighting cocktail demonstrates promising results as treatment for advanced cervical cancer 2
... different types of dementia, but these findings are shocking. We ... study", say researchers Elisabet Englund and Hans Brunnstrm at Lund ... from the cities of Lund and Malm. All of them ... period 1996-2006 and been diagnosed with some form of dementia. ...
... Boston and Google.org have found web-based search data to be ... of outbreaks of dengue, an emerging mosquito-borne virus found in ... capture of disease-related queries in near real time, it could ... affected by dengue respond more quickly to nascent epidemics. ...
... new test that identifies the specific type of tumour they ... at the University of Edinburgh hope this improved diagnosis will ... the most effective drugs. The Edinburgh team worked with ... each of which had a different genetic signature. ...
... Private health clinics across Canada providing weight-loss surgeries are ... and at the expense of quality patient care, according to ... Chaim Bell. "The private clinics in Canada offer ... banding the upper stomach to restrict food intake to patients ...
... Randy Dotinga HealthDay Reporter , MONDAY, May 30 ... are marketed heavily toward children and teens, a leading association ... kids. Young children and teens should avoid energy drinks ... issued Monday, and routine consumption of sports drinks should be ...
... Ill. Functional magnetic resonance imaging (fMRI) may provide ... researchers at Columbia University in New York City, who ... children. Results of their study appear online and in ... is a spectrum disorder characterized by repetitive behaviors and ...
Cached Medicine News:Health News:Difficulties in diagnosing dementia type 2Health News:Searching the web for dengue 2Health News:Targeted testing offers treatment hope for ovarian cancer patients 2Health News:Private weight-loss surgery clinics shedding quality patient care 2Health News:Pediatricians Group Raps Energy and Sports Drinks for Kids 2Health News:Pediatricians Group Raps Energy and Sports Drinks for Kids 3Health News:New research may lead to improved diagnosis of autism 2
Our most popular saline breast implant style for over 20 years. A full, rounded look that adds greater dimension to the breast....
This Implant enhances and restores the nasal contour, The large selection of sizes with a variety of flares and lengths allows for more individualized results...
Inquire...
... at the point of care: , Only 120 ... only 70 L of whole blood (all parameters except ... of sensor cassette , safePICO mixer ensures thorough and ... in 7 seconds) * Not ...
Medicine Products: